Global Urticaria Epidemiology and Patient Flow Analysis -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
56
Global Urticaria Epidemiology and Patient Flow Analysis - 2018: Patient Flow, Prevalence and Diagnosed & Treated Patients

Dublin, June 28, 2018 (GLOBE NEWSWIRE) -- The "Global Urticaria Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into Urticaria epidemiology, Urticaria diagnosed patients, and Urticaria treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Urticaria derived from epidemiological analysis, patients diagnosed with Urticaria, and patients treated with a drug therapy. The research study helps executives estimate Urticaria market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The research provides estimates and forecasts of Urticaria prevalence, Urticaria diagnosis rate, and Urticaria treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. Key Features of the Report

  • Urticaria Patient Flow
  • Urticaria Prevalence
  • Urticaria Diagnosed Patients
  • Urticaria Treated Patients

Key Topics Covered 1. Urticaria: Disease Definition 2. Global Urticaria Patient Flow 2A. Global Urticaria Prevalence 2B. Global Urticaria Diagnosed Patients 2C. Global Urticaria Treated Patients 3. Urticaria Patient Flow in the US 3A. Urticaria Prevalence in the US 3B. Urticaria Diagnosed Patients in the US 3C. Urticaria Treated Patients in the US 4. Urticaria Patient Flow in Europe 4A. Urticaria Prevalence in Europe 4B. Urticaria Diagnosed Patients in Europe 4C. Urticaria Treated Patients in Europe 5. Urticaria Patient Flow in Germany 5A. Urticaria Prevalence in Germany 5B. Urticaria Diagnosed Patients in Germany 5C. Urticaria Treated Patients in Germany 6. Urticaria Patient Flow in France 6A. Urticaria Prevalence in France 6B. Urticaria Diagnosed Patients in France 6C. Urticaria Treated Patients in France 7. Urticaria Patient Flow in Spain 7A. Urticaria Prevalence in Spain 7B. Urticaria Diagnosed Patients in Spain 7C. Urticaria Treated Patients in Spain 8. Urticaria Patient Flow in Italy 8A. Urticaria Prevalence in Italy 8B. Urticaria Diagnosed Patients in Italy 8C. Urticaria Treated Patients in Italy 9. Urticaria Patient Flow in UK 9A. Urticaria Prevalence in UK 9B. Urticaria Diagnosed Patients in UK 9C. Urticaria Treated Patients in UK 10. Urticaria Patient Flow in Japan 10A. Urticaria Prevalence in Japan 10B. Urticaria Diagnosed Patients in Japan 10C. Urticaria Treated Patients in Japan 11. Research Methodology For more information about this report visit https://www.researchandmarkets.com/research/v...caria?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Dermatological Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

A100x Unveils New Fund to Empower AI and Blockchain Startups

Updated Category News Views 296

A100x Launches $50 Million Fund II to Support Innovative Startups With a mission to empower early-stage companies in the domains of artificial intelligence (AI), digital assets, and blockchain technology, A100x has proudly announced its new $50 million fund. This initiative showcases A100x's commitment to fostering the next generation of innovators, building applications...

Continue Reading
Clover Health's Dr. Ian Duncan Elected SOA President-Elect

Updated Category News Views 168

Clover Health Celebrates Dr. Ian Duncan's SOA Election Clover Health, a pioneering physician enablement company, expresses its excitement over the recent election of Dr. Ian Duncan as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries (SOA). This significant announcement was made on September 12, 2025, at the SOA ImpACT Annual Conference....

Continue Reading
Stellar Cyber and LastPass Team Up for Next-Level Credential Security

Updated Category News Views 130

Revolutionizing Credential Security: Stellar Cyber and LastPass In a significant advancement for cybersecurity, Stellar Cyber and LastPass have joined forces to offer a pioneering integration that elevates credential protection to new heights. This collaboration combines Stellar Cyber’s innovative threat detection technology with the robust credential management...

Continue Reading
Quarterly Financial Results of CCA Industries, Inc. Revealed

Updated Category News Views 84

Overview of CCA Industries, Inc. Financial Performance CCA Industries, Inc. (OTC: CAWW) has recently released its financial results for the quarter and nine-month period. The findings from these reports highlight noteworthy shifts in both revenue and strategic operations. Recent Financial Results The company reported a net loss of $444,878 for the third quarter....

Continue Reading
Meritage Homes Reports Strong Q3 2024 Performance Metrics

Updated Category News Views 222

Meritage Homes Achieves Impressive Growth in Third Quarter 2024 Meritage Homes Corporation (NYSE: MTH), a leading homebuilder, disclosed its third quarter performance results, which marked a significant achievement for the company. The data reflects the period ending in September 2024, showing robust growth and positive shifts in business strategy. Notable Operating...

Continue Reading